每年出版 6 期
ISSN 打印: 1040-8401
ISSN 在线: 2162-6472
Indexed in
Immunotherapeutic Approaches for Glioma
摘要
The development of effective immunotherapy strategies for glioma requires adequate understanding of the unique immunological microenvironment in the central nervous system (CNS) and CNS tumors. Although the CNS is often considered to be an immunologically privileged site and poses unique challenges for the delivery of effector cells and molecules, recent advances in technology and discoveries in CNS immunology suggest novel mechanisms that may significantly improve the efficacy of immunotherapy against gliomas. In this review, we first summarize recent advances in the CNS and CNS tumor immunology. We address factors that may promote immune escape of gliomas. We also review advances in passive and active immunotherapy strategies for glioma, with an emphasis on lessons learned from recent early-phase clinical trials. We also discuss novel immunotherapy strategies that have been recently tested in non-CNS tumors and show great potential for application to gliomas. Finally, we discuss how each of these promising strategies can be combined to achieve clinical benefit for patients with gliomas.
-
Gubanova N. V., Gaytan A. S., Razumov I. A., Mordvinov V. A., Krivoshapkin A. L., Netesov S. V., Chumakov P. M., Oncolytic viruses in the therapy of gliomas, Molecular Biology, 46, 6, 2012. Crossref
-
Cartron Pierre-François, Blanquart Christophe, Hervouet Eric, Gregoire Marc, Vallette François M., HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression, Molecular Oncology, 7, 3, 2013. Crossref
-
Okada Hideho, Pollack Ian F, Do we need novel radiologic response criteria for brain tumor immunotherapy?, Expert Review of Neurotherapeutics, 11, 5, 2011. Crossref
-
Verschuere Tina, De Vleeschouwer Steven, Lefranc Florence, Kiss Robert, Van Gool Stefaan W, Galectin-1 and immunotherapy for brain cancer, Expert Review of Neurotherapeutics, 11, 4, 2011. Crossref
-
Kohanbash Gary, Okada Hideho, Myeloid-derived Suppressor Cells (MDSCs) in Gliomas and Glioma-Development, Immunological Investigations, 41, 6-7, 2012. Crossref
-
Pellegatta Serena, Eoli Marica, Frigerio Simona, Antozzi Carlo, Bruzzone Maria Grazia, Cantini Gabriele, Nava Sara, Anghileri Elena, Cuppini Lucia, Cuccarini Valeria, Ciusani Emilio, Dossena Marta, Pollo Bianca, Mantegazza Renato, Parati Eugenio A., Finocchiaro Gaetano, The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates, OncoImmunology, 2, 3, 2013. Crossref
-
Iwami Kenichiro, Shimato Shinji, Ohno Masasuke, Okada Hideho, Nakahara Norimoto, Sato Yuichiro, Yoshida Jun, Suzuki Satoshi, Nishikawa Hiroyoshi, Shiku Hiroshi, Natsume Atsushi, Wakabayashi Toshihiko, Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele, Cytotherapy, 14, 6, 2012. Crossref
-
Ohno Masasuke, Ohkuri Takayuki, Kosaka Akemi, Tanahashi Kuniaki, June Carl H, Natsume Atsushi, Okada Hideho, Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts, Journal for ImmunoTherapy of Cancer, 1, 1, 2013. Crossref
-
Kohanbash Gary, Ishikawa Eiichi, Fujita Mitsugu, Ikeura Maki, McKaveney Kayla, Zhu Jianzhong, Sakaki Masashi, Sarkar Saumendra N., Okada Hideho, Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma, OncoImmunology, 1, 4, 2012. Crossref
-
Pollack Ian F, Jakacki Regina I, Butterfield Lisa H, Okada Hideho, Ependymomas: development of immunotherapeutic strategies, Expert Review of Neurotherapeutics, 13, 10, 2013. Crossref
-
Muragaki Yoshihiro, Maruyama Takashi, Iseki Hiroshi, Tanaka Masahiko, Shinohara Chie, Takakura Kintomo, Tsuboi Koji, Yamamoto Tetsuya, Matsumura Akira, Matsutani Masao, Karasawa Katsuyuki, Shimada Katsunori, Yamaguchi Naohito, Nakazato Yoichi, Sato Keiki, Uemae Youji, Ohno Tadao, Okada Yoshikazu, Hori Tomokatsu, Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma, Journal of Neurosurgery, 115, 2, 2011. Crossref
-
Pedron S., Harley B. A. C., Impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy, Journal of Biomedical Materials Research Part A, 101, 12, 2013. Crossref
-
Galvão Rui Pedro, Zong Hui, Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression, Current Pathobiology Reports, 1, 1, 2013. Crossref
-
Kastenhuber Edward R., Huse Jason T., Berman Samuel H., Pedraza Alicia, Zhang Jianan, Suehara Yoshiyuki, Viale Agnes, Cavatore Magali, Heguy Adriana, Szerlip Nicholas, Ladanyi Marc, Brennan Cameron W., Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates, Acta Neuropathologica, 127, 5, 2014. Crossref
-
Tarassishin Leonid, Lee Sunhee C., Interferon regulatory factor 3 alters glioma inflammatory and invasive properties, Journal of Neuro-Oncology, 113, 2, 2013. Crossref
-
Ma Chengyuan, Li Yang, Li Zhixin, Huang Haiyan, Xu Kan, Xu Haiyang, Bai Jieying, Li Xiao, Zhao Gang, Synthesis and purification of a toxin-linked conjugate targeting epidermal growth factor receptor in Escherichia coli, Protein Expression and Purification, 83, 1, 2012. Crossref
-
Newcomb Elizabeth W., Lukyanov Yevgeniy, Kawashima Noriko, Alonso-Basanta Michelle, Wang Shu-Chi, Liu Mengling, Jure-Kunkel Maria, Zagzag David, Demaria Sandra, Formenti Silvia C., Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy in a Mouse Glioma Model, Radiation Research, 173, 4, 2010. Crossref
-
Zhang Leying, Liu Wei, Alizadeh Darya, Zhao Dongchang, Farrukh Omar, Lin Jeffrey, Badie Sam A., Badie Behnam, S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathway, Glia, 59, 3, 2011. Crossref
-
Okada Hideho, Brain Tumor Immunotherapy with Type-1 Polarizing Strategies, Annals of the New York Academy of Sciences, 1174, 1, 2009. Crossref
-
Krebs Simone, Chow Kevin K.H., Yi Zhongzhen, Rodriguez-Cruz Tania, Hegde Meenakshi, Gerken Claudia, Ahmed Nabil, Gottschalk Stephen, T cells redirected to interleukin-13Rα2 with interleukin-13 mutein–chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1, Cytotherapy, 16, 8, 2014. Crossref
-
Ahn Brian, Pollack Ian, Okada Hideho, Immune-Checkpoint Blockade and Active Immunotherapy for Glioma, Cancers, 5, 4, 2013. Crossref
-
Foreman Nicholas K., Donson Andrew M., Tumor vaccination for malignant brain tumors, Pediatric Blood & Cancer, 54, 4, 2010. Crossref
-
Dietrich Pierre-Yves, Dutoit Valérie, Tran Thang Nhu Nam, Walker Paul R, T-cell immunotherapy for malignant glioma: toward a combined approach, Current Opinion in Oncology, 22, 6, 2010. Crossref
-
Chen P.-Y., Liu H.-L., Hua M.-Y., Yang H.-W., Huang C.-Y., Chu P.-C., Lyu L.-A., Tseng I.-C., Feng L.-Y., Tsai H.-C., Chen S.-M., Lu Y.-J., Wang J.-J., Yen T.-C., Ma Y.-H., Wu T., Chen J.-P., Chuang J.-I., Shin J.-W., Hsueh C., Wei K.-C., Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment, Neuro-Oncology, 12, 10, 2010. Crossref
-
Lee Ian Y., Kalkanis Steven N., Rosenblum Mark L., Malignant Gliomas: Current Concepts, Neurosurgery Quarterly, 20, 3, 2010. Crossref
-
Vauleon Elodie, Avril Tony, Collet Brigitte, Mosser Jean, Quillien Véronique, Overview of Cellular Immunotherapy for Patients with Glioblastoma, Clinical and Developmental Immunology, 2010, 2010. Crossref
-
Ohno Masasuke, Natsume Atsushi, Ichiro Iwami Ken, Iwamizu Hidetaka, Noritake Kana, Ito Daiki, Toi Yuki, Ito Motokazu, Motomura Kazuya, Yoshida Jun, Yoshikawa Kazuhiro, Wakabayashi Toshihiko, Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen, Cancer Science, 101, 12, 2010. Crossref
-
Landi Daniel, Hegde Meenakshi, Ahmed Nabil, Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy, Frontiers in Oncology, 4, 2014. Crossref
-
Zhao Dongchang, Badie Behnam, Application of Carbon Nanotubes to Brain Tumor Therapy, in Nanotechnologies for the Life Sciences, 2012. Crossref
-
Zhu Xinmei, Fujita Mitsugu, Snyder Linda A., Okada Hideho, Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy, Journal of Neuro-Oncology, 104, 1, 2011. Crossref
-
Holzmüller Regina, Mantwill Klaus, Haczek Cornelia, Rognoni Emanuel, Anton Martina, Kasajima Atsuko, Weichert Wilko, Treue Denise, Lage Hermann, Schuster Tibor, Schlegel Jürgen, Gänsbacher Bernd, Holm Per S., YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma, International Journal of Cancer, 129, 5, 2011. Crossref
-
Finocchiaro Gaetano, Pellegatta Serena, Immunotherapy for glioma, Current Opinion in Neurology, 24, 6, 2011. Crossref
-
Moravan Michael J., Olschowka John A., Williams Jacqueline P., O'Banion M. Kerry, Cranial Irradiation Leads to Acute and Persistent Neuroinflammation with Delayed Increases in T-Cell Infiltration and CD11c Expression in C57BL/6 Mouse Brain, Radiation Research, 176, 4, 2011. Crossref
-
Kalinski Pawel, Okada Hideho, Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors, Seminars in Immunology, 22, 3, 2010. Crossref
-
Kohanbash Gary, Okada Hideho, MicroRNAs and STAT interplay, Seminars in Cancer Biology, 22, 1, 2012. Crossref
-
Revoltella Roberto P., Menicagli Michele, Campani Daniela, Granulocyte–macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas, Cytokine, 57, 3, 2012. Crossref
-
Zhu Vivian F., Yang Jingxuan, LeBrun Drake G., Li Min, Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis, Cancer Letters, 316, 2, 2012. Crossref
-
Gardner Sharon L., Ahmed Nabil, Okada Hideho, Immunotherapy for Pediatric Central Nervous System Tumors, Biology of Blood and Marrow Transplantation, 16, 1, 2010. Crossref
-
Okada Hideho, Kohanbash Gary, Lotze Michael T., MicroRNAs in immune regulation—Opportunities for cancer immunotherapy, The International Journal of Biochemistry & Cell Biology, 42, 8, 2010. Crossref
-
Xu Xun, Stockhammer Florian, Schmitt Michael, Cellular-Based Immunotherapies for Patients with Glioblastoma Multiforme, Clinical and Developmental Immunology, 2012, 2012. Crossref
-
Liu Yan, Komohara Yoshihiro, Domenick Natalie, Ohno Masasuke, Ikeura Maki, Hamilton Ronald L., Horbinski Craig, Wang Xinhui, Ferrone Soldano, Okada Hideho, Expression of antigen processing and presenting molecules in brain metastasis of breast cancer, Cancer Immunology, Immunotherapy, 61, 6, 2012. Crossref
-
LI HONGWEI, ZHENG JUNNING, GUAN RUIYUN, ZHU ZIFENG, YUAN XIANHOU, Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo, Oncology Letters, 10, 6, 2015. Crossref
-
Kamran Neha, Calinescu Alexandra, Candolfi Marianela, Chandran Mayuri, Mineharu Yohei, Asad Antonela S., Koschmann Carl, Nunez Felipe J., Lowenstein Pedro R., Castro Maria G., Recent advances and future of immunotherapy for glioblastoma, Expert Opinion on Biological Therapy, 16, 10, 2016. Crossref
-
Dutoit Valérie, Migliorini Denis, Dietrich Pierre-Yves, Walker Paul R., Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?, Frontiers in Oncology, 6, 2016. Crossref
-
Liebelt Brandon D., Finocchiaro Gaetano, Heimberger Amy B., Principles of immunotherapy, in Gliomas, 134, 2016. Crossref
-
Volovitz Ilan, Shapira Netanel, Ezer Haim, Gafni Aviv, Lustgarten Merav, Alter Tal, Ben-Horin Idan, Barzilai Ori, Shahar Tal, Kanner Andrew, Fried Itzhak, Veshchev Igor, Grossman Rachel, Ram Zvi, A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells, BMC Neuroscience, 17, 1, 2016. Crossref
-
Parvez Kashif, Parvez Aatif, Zadeh Gelareh, The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence, International Journal of Molecular Sciences, 15, 7, 2014. Crossref
-
Zhong Jia, Sakaki Masashi, Okada Hideho, Ahrens Eric T., Mosley R. Lee, In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging, PLoS ONE, 8, 5, 2013. Crossref
-
Tarassishin Leonid, Casper Diana, Lee Sunhee C., Ulasov Ilya, Aberrant Expression of Interleukin-1β and Inflammasome Activation in Human Malignant Gliomas, PLoS ONE, 9, 7, 2014. Crossref
-
Laudati Emilia, Currò Diego, Navarra Pierluigi, Lisi Lucia, Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm, Neurochemistry International, 108, 2017. Crossref
-
Liu Hongyu, Chen Ling, Liu Jialin, Meng Hengxing, Zhang Rong, Ma Lin, Wu Liangliang, Yu Songyan, Shi Fei, Li Ying, Zhang Lijun, Wang Lingxiong, Feng Shiyu, Zhang Qi, Peng Yaojun, Wu Qiyan, Liu Chunxi, Chang Xin, Yang Lin, Uemura Yasushi, Yu Xinguang, Liu Tianyi, Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma, Cancer Letters, 411, 2017. Crossref
-
Nieto-Sampedro Manuel, Valle-Argos Beatriz, Gómez-Nicola Diego, Fernández-Mayoralas Alfonso, Nieto-Díaz Manuel, Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System, Clinical Medicine Insights: Oncology, 5, 2011. Crossref
-
JOVČEVSKA IVANA, KOČEVAR NINA, KOMEL RADOVAN, Glioma and glioblastoma - how much do we (not) know?, Molecular and Clinical Oncology, 1, 6, 2013. Crossref
-
Margiewicz Stefan, Cordova Christine, Chi Andrew S., Jain Rajan, State of the Art Treatment and Surveillance Imaging of Glioblastomas, Seminars in Roentgenology, 53, 1, 2018. Crossref
-
Mehta Swapnil, Shah Aatman, Jung Henry, Diagnosis and treatment options for sequelae following radiation treatment of brain tumors, Clinical Neurology and Neurosurgery, 163, 2017. Crossref
-
Hira Zena M., Gillies Duncan F., Identifying Significant Features in Cancer Methylation Data Using Gene Pathway Segmentation, Cancer Informatics, 15, 2016. Crossref
-
Chheda Zinal S., Kohanbash Gary, Okada Kaori, Jahan Naznin, Sidney John, Pecoraro Matteo, Yang Xinbo, Carrera Diego A., Downey Kira M., Shrivastav Shruti, Liu Shuming, Lin Yi, Lagisetti Chetana, Chuntova Pavlina, Watchmaker Payal B., Mueller Sabine, Pollack Ian F., Rajalingam Raja, Carcaboso Angel M., Mann Matthias, Sette Alessandro, Garcia K. Christopher, Hou Yafei, Okada Hideho, Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy, Journal of Experimental Medicine, 215, 1, 2018. Crossref
-
Rajesh Y, Pal Ipsita, Banik Payel, Chakraborty Sandipan, Borkar Sachin A, Dey Goutam, Mukherjee Ahona, Mandal Mahitosh, Insights into molecular therapy of glioma: current challenges and next generation blueprint, Acta Pharmacologica Sinica, 38, 5, 2017. Crossref
-
Sonabend Adam M., Showers Christopher R., Anderson Richard C. E., Immunopathology and Immunotherapy of Central Nervous System Cancer, in Cancer Immunology, 2015. Crossref
-
Nandu Hari, Wen Patrick Y., Huang Raymond Y., Imaging in neuro-oncology, Therapeutic Advances in Neurological Disorders, 11, 2018. Crossref
-
Filley Anna C., Henriquez Mario, Dey Mahua, CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors, Frontiers in Oncology, 8, 2018. Crossref
-
ISHIDA ATSUSHI, WATANABE MIKA, MATSUO SEIGO, NIIMURA KAKU, YOSHIMOTO HARUKO, ASAKUNO KEIZOH, SHIRAMIZU HIDEKI, NEMOTO AKIO, YUZAWA MIKI, HORI TOMOKATSU, Achievement of three year remission in a case of aggressive glioblastoma using a multidisciplinary treatment strategy: A case report, Oncology Letters, 7, 5, 2014. Crossref
-
Hanaei Sara, Afshari Khashayar, Hirbod-Mobarakeh Armin, Mohajer Bahram, Amir Dastmalchi Delara, Rezaei Nima, Therapeutic efficacy of specific immunotherapy for glioma: a systematic review and meta-analysis, Reviews in the Neurosciences, 29, 4, 2018. Crossref
-
Oberheim Bush Nancyann, Cha Soonmee, Chang Susan, Clarke Jennifer L., Pseudo-Progression in Neuro-Oncology: Overview, Pathophysiology, and Interpretation, in Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, 2018. Crossref
-
LIU ZENGJIN, HAN HUAMIN, HE XIN, LI SHOUWEI, WU CHENXING, YU CHUNJIANG, WANG SHENGDIAN, Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma, Oncology Letters, 11, 3, 2016. Crossref
-
Brown Casey B., Jacobs Susanne, Johnson Mark P., Southerland Cindy, Threatt Stevie, Convection-Enhanced Delivery in the Treatment of Glioblastoma, Seminars in Oncology Nursing, 34, 5, 2018. Crossref
-
Rapp Marion, Grauer Oliver M., Kamp Marcel, Sevens Natalie, Zotz Nikola, Sabel Michael, Sorg Rüdiger V., A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial, Trials, 19, 1, 2018. Crossref
-
Pope Whitney B., Brandal Garth, Conventional and advanced magnetic resonance imaging in patients with high-grade glioma, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 62, 3, 2018. Crossref
-
Nigam Shubhanchi, McCarl Lauren, Kumar Rajeev, Edinger Robert S., Kurland Brenda F., Anderson Carolyn J., Panigrahy Ashok, Kohanbash Gary, Edwards W. Barry, Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody, Molecular Imaging and Biology, 22, 3, 2020. Crossref
-
Chuntova Pavlina, Downey Kira M., Hegde Bindu, Almeida Neil D., Okada Hideho, Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy, Frontiers in Immunology, 9, 2019. Crossref
-
Armstrong Carol L., Schmus Cynthia J., Belasco Jean B., Li Yimei, Neuropsychological Problems in Neuro-Oncology, in Handbook of Medical Neuropsychology, 2019. Crossref
-
Mortazavi Martin M., Ahmadi Jazi Ghazaleh, Sadati Mohsen, Zakowicz Kamila, Sheikh Sarvenaz, Khalili Kianoush, Adl Farzad H., Taqi Muhammad A., Nguyen Ha S., Tubbs R. Shane, Modern operative nuances for the management of eloquent high-grade gliomas, Journal of Neurosurgical Sciences, 63, 2, 2019. Crossref
-
Santegoets Kim C. M., Gielen Paul R., Büll Christian, Schulte Barbara M., Kers-Rebel Esther D., Küsters Benno, Bossman Sandra A. J. F. H., ter Laan Mark, Wesseling Pieter, Adema Gosse J., Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma, Cancer Immunology, Immunotherapy, 68, 6, 2019. Crossref
-
Liang Tingyu, Wang Xiaoxuan, Wang Fang, Feng Enshan, You Gan, Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response in Glioma Patients, World Neurosurgery, 132, 2019. Crossref
-
Strauss Sara B., Meng Alicia, Ebani Edward J., Chiang Gloria C., Imaging Glioblastoma Posttreatment, Radiologic Clinics of North America, 57, 6, 2019. Crossref
-
Li Zhenhua, Mukherjee Debraj, Lee Jang-Won, Yu John S., Molecular targeting of cancer stem cells, in Cancer Vaccines: From Research to Clinical Practice, 2011. Crossref
-
Litterman Adam J., Zellmer David M., Grinnen Karen L., Hunt Matthew A., Dudek Arkadiusz Z., Salazar Andres M., Ohlfest John R., Profound Impairment of Adaptive Immune Responses by Alkylating Chemotherapy, The Journal of Immunology, 190, 12, 2013. Crossref
-
Volovitz Ilan, Marmor Yotvat, Azulay Meir, Machlenkin Arthur, Goldberger Ofir, Mor Felix, Slavin Shimon, Ram Zvi, Cohen Irun R., Eisenbach Lea, Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells, The Journal of Immunology, 187, 10, 2011. Crossref
-
Mannem Chandana, Xu Yan, An LC–MS/MS method for determination of O 6 ‐benzylguanine and its metabolite O 6 ‐benzyl‐8‐oxoguanine in human plasma , Biomedical Chromatography, 34, 2, 2020. Crossref
-
Nejo Takahide, Yamamichi Akane, Almeida Neil D., Goretsky Yitzhar E., Okada Hideho, Tumor antigens in glioma, Seminars in Immunology, 47, 2020. Crossref
-
Pavon Lorena Favaro, Sibov Tatiana Tais, de Oliveira Daniela Mara, Marti Luciana C., Cabral Francisco Romero, de Souza Jean Gabriel, Boufleur Pamela, Malheiros Suzana M.F., de Paiva Neto Manuel A., da Cruz Edgard Ferreira, Chudzinski-Tavassi Ana Marisa, Cavalheiro Sérgio, Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cells, Oncotarget, 7, 26, 2016. Crossref
-
Feng Yong, Shen Jacson, Gao Yan, Liao Yunfei, Cote Gregory, Choy Edwin, Chebib Ivan, Mankin Henry, Hornicek Francis, Duan Zhenfeng, Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma, Oncotarget, 6, 13, 2015. Crossref
-
Nilsen Line Brennhaug, Emblem Kyrre Eeg, Magnetic Resonance Imaging for Quantification of Brain Vascular Perfusion, in Brain Tumors, 158, 2021. Crossref
-
Strauss Sara B., Meng Alicia, Ebani Edward J., Chiang Gloria C., Imaging Glioblastoma Posttreatment, Neuroimaging Clinics of North America, 31, 1, 2021. Crossref
-
Hanaei Sara, Arrieta Víctor Andrés, Sonabend Adam M., Immunopathology and Immunotherapy of Central Nervous System Cancer, in Cancer Immunology, 2020. Crossref
-
Okada Hideho, Weller Michael, Huang Raymond, Finocchiaro Gaetano, Gilbert Mark R, Wick Wolfgang, Ellingson Benjamin M, Hashimoto Naoya, Pollack Ian F, Brandes Alba A, Franceschi Enrico, Herold-Mende Christel, Nayak Lakshmi, Panigrahy Ashok, Pope Whitney B, Prins Robert, Sampson John H, Wen Patrick Y, Reardon David A, Immunotherapy response assessment in neuro-oncology: a report of the RANO working group, The Lancet Oncology, 16, 15, 2015. Crossref
-
Kavya S.G., Reghu R., An Overview of High-grade Glioma: Current and Emerging Treatment Approaches, Current Cancer Therapy Reviews, 17, 1, 2021. Crossref
-
Ma Ruimin, Jiang Tao, Kang Xixiong, Circulating microRNAs in cancer: origin, function and application, Journal of Experimental & Clinical Cancer Research, 31, 1, 2012. Crossref
-
Zhang Hongtao, Tian Miao, Xiu Chunming, Wang Yunbo, Tang Guotai, Enhancement of Antitumor Activity by Combination of Tumor Lysate-Pulsed Dendritic Cells and Celecoxib in a Rat Glioma Model, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 20, 10, 2012. Crossref
-
Kilian Michael, Bunse Theresa, Wick Wolfgang, Platten Michael, Bunse Lukas, Genetically Modified Cellular Therapies for Malignant Gliomas, International Journal of Molecular Sciences, 22, 23, 2021. Crossref
-
Shen Shaoping, Wu Qiyan, Liu Jialin, Wu Liangliang, Zhang Rong, Uemura Yasushi, Yu Xinguang, Chen Ling, Liu Tianyi, Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood, International Journal of Immunopathology and Pharmacology, 35, 2021. Crossref
-
Dong Taiwei, Chen Nian, Ma Xiao, Wang Jian, Wen Jing, Xie Qian, Ma Rong, The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit, Biomedicine & Pharmacotherapy, 102, 2018. Crossref
-
Chow Kevin KH, Gottschalk Stephen, Cellular immunotherapy for high-grade glioma, Immunotherapy, 3, 3, 2011. Crossref
-
Song Tao, Zhang Mingyu, Wu Jun, Chen Fenghua, Wang Ying, Ma Yujie, Dai Zhijie, Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo, Investigational New Drugs, 38, 6, 2020. Crossref
-
Couto Marina, Coelho‐Santos Vanessa, Santos Liliana, Fontes‐Ribeiro Carlos, Silva Ana Paula, Gomes Célia M. F., The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin‐6‐induced JAK2/STAT3 pathway, Journal of Cellular Physiology, 234, 11, 2019. Crossref
-
Guo Zhigang, Guozhang Hu, Wang Hang, Li Zhaohui, Liu Naijie, Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway, Biomedicine & Pharmacotherapy, 116, 2019. Crossref
-
Murphy Katherine A., Lechner Melissa G., Popescu Flavia E., Bedi Jessica, Decker Stacy A., Hu Peisheng, Erickson Jami R., O'Sullivan M. Gerard, Swier Lauryn, Salazar Andres M., Olin Michael R., Epstein Alan L., Ohlfest John R., An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas, Clinical Cancer Research, 18, 17, 2012. Crossref
-
Kristin Schmitz Ann, Sorg Rüdiger V., Stoffels Gabriele, Grauer Oliver M., Galldiks Norbert, Steiger Hans-Jakob, Kamp Marcel A., Langen Karl-Josef, Sabel Michael, Rapp Marion, Diagnostic impact of additional O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET following immunotherapy with dendritic cell vaccination in glioblastoma patients, British Journal of Neurosurgery, 35, 6, 2021. Crossref
-
Ueda Ryo, Fujita Mitsugu, Zhu Xinmei, Sasaki Kotaro, Kastenhuber Edward R., Kohanbash Gary, McDonald Heather A., Harper Jay, Lonning Scott, Okada Hideho, Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines, Clinical Cancer Research, 15, 21, 2009. Crossref
-
Hwang Eugene I., Sayour Elias J., Flores Catherine T., Grant Gerald, Wechsler-Reya Robert, Hoang-Minh Lan B., Kieran Mark W., Salcido Joanne, Prins Robert M., Figg John W., Platten Michael, Candelario Kate M., Hale Paul G., Blatt Jason E., Governale Lance S., Okada Hideho, Mitchell Duane A., Pollack Ian F., The current landscape of immunotherapy for pediatric brain tumors, Nature Cancer, 3, 1, 2022. Crossref
-
Fujita Mitsugu, Scheurer Michael E., Decker Stacy A., McDonald Heather A., Kohanbash Gary, Kastenhuber Edward R., Kato Hisashi, Bondy Melissa L., Ohlfest John R., Okada Hideho, Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans, Clinical Cancer Research, 16, 13, 2010. Crossref
-
Kohanbash Gary, McKaveney Kayla, Sakaki Masashi, Ueda Ryo, Mintz Arlan H., Amankulor Nduka, Fujita Mitsugu, Ohlfest John R., Okada Hideho, GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α, Cancer Research, 73, 21, 2013. Crossref
-
Johnson Laura A., Scholler John, Ohkuri Takayuki, Kosaka Akemi, Patel Prachi R., McGettigan Shannon E., Nace Arben K., Dentchev Tzvete, Thekkat Pramod, Loew Andreas, Boesteanu Alina C., Cogdill Alexandria P., Chen Taylor, Fraietta Joseph A., Kloss Christopher C., Posey Avery D., Engels Boris, Singh Reshma, Ezell Tucker, Idamakanti Neeraja, Ramones Melissa H., Li Na, Zhou Li, Plesa Gabriela, Seykora John T., Okada Hideho, June Carl H., Brogdon Jennifer L., Maus Marcela V., Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma, Science Translational Medicine, 7, 275, 2015. Crossref
-
Bloch Orin, Crane Courtney A., Kaur Rajwant, Safaee Michael, Rutkowski Martin J., Parsa Andrew T., Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages, Clinical Cancer Research, 19, 12, 2013. Crossref
-
Pollack Ian F., Jakacki Regina I., Butterfield Lisa H., Okada Hideho, Peptide Vaccine Therapy for Childhood Gliomas, Neurosurgery, 60, Supplement 1, 2013. Crossref
-
Okada Hideho, Kalinski Pawel, Ueda Ryo, Hoji Aki, Kohanbash Gary, Donegan Teresa E., Mintz Arlan H., Engh Johnathan A., Bartlett David L., Brown Charles K., Zeh Herbert, Holtzman Matthew P., Reinhart Todd A., Whiteside Theresa L., Butterfield Lisa H., Hamilton Ronald L., Potter Douglas M., Pollack Ian F., Salazar Andres M., Lieberman Frank S., Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma, Journal of Clinical Oncology, 29, 3, 2011. Crossref
-
Clavreul Anne, Piard Nicole, Tanguy Jean-Yves, Gamelin Eric, Rousselet Marie-Christine, Leynia Pierre, Menei Philippe, Autologous tumor cell vaccination plus infusion of GM-CSF by a programmable pump in the treatment of recurrent malignant gliomas, Journal of Clinical Neuroscience, 17, 7, 2010. Crossref
-
Oberheim Bush Nancy Ann, Clarke Jennifer L., Pseudo-progression in neuro-oncology, in Handbook of Neuro-Oncology Neuroimaging, 2022. Crossref
-
Lowe Stephen R., Sattur Mithun G., Vogelbaum Michael A., Response assessment in neuro-oncology criteria, in Handbook of Neuro-Oncology Neuroimaging, 2022. Crossref